08/21/2025
3:04 PM | Ridloff Elena (Reporting)
Sionna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2025
3:05 PM | Cloonan Michael (Reporting)
Sionna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2025
3:26 PM | Ridloff Elena (Reporting)
Sionna Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2025
3:22 PM | Cloonan Michael (Reporting)
Sionna Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/19/2025
3:26 PM | Ridloff Elena (Reporting)
Sionna Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/11/2025
6:13 AM | Sionna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2025
6:21 AM | Sionna Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/30/2025
12:19 PM | JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Sionna Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/16/2025
4:06 PM | Booth Bruce (Reporting)
Sionna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:06 PM | Clancy Paul J (Reporting)
Sionna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:07 PM | Fleming Harold Edward (Reporting)
Sionna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for SION and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Sionna Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/16/2025
4:07 PM | Resnick Joshua (Reporting)
Sionna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:07 PM | Ruddy Marcella K. (Reporting)
Sionna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:08 PM | Sionna Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:08 PM | Sionna Therapeutics (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:08 PM | Sionna Therapeutics (Issuer)
Viney Joanne L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:15 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Sionna Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
6:37 AM | Qatar Investment Authority (Filed by)
Sionna Therapeutics (Subject)
| Form SCHEDULE 13G | |
06/04/2025
6:13 AM | Sionna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
6:12 AM | Sionna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/12/2025
6:31 AM | Sionna Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
6:28 AM | Sionna Therapeutics (Filer)
| Form DEF 14A | |
04/29/2025
6:31 AM | Sionna Therapeutics (Filer)
| Form DEFA14A | |
04/29/2025
6:33 AM | Sionna Therapeutics (Filer)
| Form ARS | |
03/20/2025
6:27 AM | Sionna Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/20/2025
6:15 AM | Sionna Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
7:56 PM | Sionna Therapeutics (Subject)
TPG GP A, LLC (Filed by)
| Form SCHEDULE 13D | |
02/13/2025
3:47 PM | ORBIMED ADVISORS LLC (Filed by)
Sionna Therapeutics (Subject)
| Form SCHEDULE 13D | |
02/12/2025
4:21 PM | COULTER JAMES G (Reporting)
Sionna Therapeutics (Issuer)
TPG GP A, LLC (Reporting)
WINKELRIED JON (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2025
3:46 PM | Sionna Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/06/2025
11:15 PM | Sionna Therapeutics (Filer)
| Form EFFECT | |
02/06/2025
8:36 PM | COULTER JAMES G (Reporting)
Sionna Therapeutics (Issuer)
TPG GP A, LLC (Reporting)
WINKELRIED JON (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:18 PM | McKee Charlotte (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:18 PM | ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:22 PM | Sionna Therapeutics (Issuer)
Stelzer Laurie (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:06 PM | Sionna Therapeutics (Issuer)
Thompson Peter A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:07 PM | Kolchinsky Peter (Reporting)
RA Capital Healthcare Fund LP (Reporting)
RA CAPITAL MANAGEMENT, L.P. (Reporting)
RA Capital Nexus Fund III, L.P. (Reporting)
RA Capital Nexus Fund, L.P. (Reporting)
Shah Rajeev M. (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:09 PM | Cloonan Michael (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:12 PM | Atlas Venture Associates Opportunity II, LLC (Reporting)
Atlas Venture Associates Opportunity II, LP (Reporting)
Atlas Venture Associates XI, L.P. (Reporting)
Atlas Venture Associates XI, LLC (Reporting)
Atlas Venture Fund XI, L.P. (Reporting)
Atlas Venture Opportunity Fund II, L.P. (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:15 PM | Ruddy Marcella K. (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:15 PM | Iancovici Lucian (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
When the levee breaks (Ad) The U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was projected. According to Porter Stansberry, this is panic-level borrowing… and a clear sign we’re nearing America’s financial breaking point.
In his latest emergency briefing, Porter outlines why the cracks in our system are widening fast—and how Trump’s policies may be accelerating the collapse. More importantly, he reveals three moves you can make now to protect and potentially grow your wealth before the levee breaks. Click here to watch the urgent broadcast and get ahead of what’s coming. |
02/06/2025
7:58 PM | Booth Bruce (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:00 PM | Ridloff Elena (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:02 PM | Clancy Paul J (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:02 PM | Fleming Harold Edward (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:05 PM | Resnick Joshua (Reporting)
Sionna Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
8:05 PM | Sionna Therapeutics (Issuer)
Viney Joanne L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/06/2025
6:00 PM | Sionna Therapeutics (Filer)
| Form S-1MEF | |
02/06/2025
10:56 AM | Sionna Therapeutics (Filer)
| Form CERT | |
02/04/2025
3:07 PM | Sionna Therapeutics (Filer)
| Form 8-A12B | |
02/03/2025
5:06 AM | Sionna Therapeutics (Filer)
| Form S-1/A | |
01/17/2025
4:00 PM | Sionna Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
MarketBeat All Access